Corporate Update – Sera Prognostics (SERA)
Trading Activity
- Sera Prognostics traded flat (0 %) during the 24‑hour period ending at 05:21 PM Central Europe on Wednesday 21 Oct 2026.
- The current trading price is USD 2.03 per share on major exchanges.
- Total shares outstanding are 39.4 million.
- Market capitalisation stands at USD 80.1 million.
- Volume traded in the last 24 hours is approximately USD 63.5 k.
Performance Metrics
- Year‑to‑date change: –4.25 % since the end of last month.
- 200‑day simple moving average: USD 2.18.
- 52‑week high: USD 3.95 (27 Oct 2025).
- 52‑week low: USD 1.56 (14 May 2026).
Comparable Stock Performance – 24 Hours
| Symbol | Trade Direction | Current Price (USD) | Market Cap (USD mn) | P/E Ratio |
|---|---|---|---|---|
| ICCC | Down –0.57 % | 10.40 | 95.5 | 141.29 |
| LAKE | Up 1.28 % | 9.28 | 93.2 | – |
| OESX | Down –5.75 % | 21.41 | 93.2 | 4 272.22 |
| ZVIA | Flat 0 % | 1.23 | 94.4 | – |
| PLYX | Down –0.52 % | 1.90 | 95.7 | – |
Recent Developments – Orion Energy (OESX)
- Orion Energy Systems, Inc. announced new contracts with a major global automotive manufacturer for LED lighting, electrical infrastructure, and electric‑vehicle charging station deployments at U.S. manufacturing and distribution sites.
- The expansion represents the first EV‑charging installation with this customer and is expected to generate additional revenue in the upcoming fiscal year.
- A Schedule 13G filed by AIGH Capital Management and associated parties reports a 9.9 % ownership stake, equivalent to roughly 407,000 shares. The filing confirms beneficial ownership but does not indicate a controlling interest.
Company Profile – Sera Prognostics, Inc.
- Headquarters: Salt Lake City, Utah, United States.
- Industry: Health diagnostics.
- Core products: Diagnostic and blood tests for predicting and managing pregnancy complications such as preterm birth and preeclampsia.
- Distribution channels: Clinics and hospitals nationwide.
- Listing: Nasdaq stock exchange.
- Website: www.seraprognostics.com